Jakafi 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FQLP5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,721
Award facts
- Contract value 100% obligated
- $12,720.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $12.7K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count packages). This firm fixed-price delivery order, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, was awarded without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The order will be fulfilled from the vendor's Park Ridge location and represents a routine procurement action under the company's existing contract vehicle with the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. The underlying IDC, awarded in November 2025 with a $500 million ceiling and completion date of December 31, 2036, establishes DMS Pharmaceutical Group as one of multiple regional prime vendor contractors authorized to provide firm fixed-price delivery orders for branded and generic prescription medications, biologics, and medical consumables supporting military healthcare operations globally. The company's substantial prior performance on similar delivery orders demonstrates its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQLP5?
SPE2DR26FQLP5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FQLP5 worth?
The government has obligated $12,721 on SPE2DR26FQLP5.
Is contract SPE2DR26FQLP5 an order under another contract?
Yes. SPE2DR26FQLP5 is a delivery order under SPE2DR25D9354, an indefinite delivery contract.
Was contract SPE2DR26FQLP5 competed?
The extent of competition for SPE2DR26FQLP5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award